Publication:
Current updates and future perspectives in uric acid research, 2024

dc.contributor.coauthorKuwabara, Masanari
dc.contributor.coauthorAe, Ryusuke
dc.contributor.coauthorKosami, Koki
dc.contributor.coauthorAndres-Hernando, Ana
dc.contributor.coauthorHisatome, Ichiro
dc.contributor.coauthorLanaspa, Miguel A.
dc.contributor.departmentSchool of Medicine
dc.contributor.kuauthorKanbay, Mehmet
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.date.accessioned2025-03-06T20:58:30Z
dc.date.issued2024
dc.description.abstractUric acid, the final product of purine metabolism, plays a significant role in hypertension Research on uric acid has advanced significantly, particularly regarding its links to hypertension and cardiovascular disease (CVD). Our 2023 review covered the relationship between uric acid, hypertension;and CVD, however, numerous new studies have emerged since then. This paper provides an update, summarizing recent findings over the past two years on hyperuricemia and its association with hypertension, preeclampsia, arteriosclerosis, kidney disease, sleep-disordered breathing, CVD, and so on. Hyperuricemia, often driven by reduced uric acid excretion or increased production, is influenced by genetic factors and lifestyle habits, including high-purine foods, alcohol, and fructose intake. While hyperuricemia has been proposed to contribute to hypertension and CVD through mechanisms like inflammasome activation and oxidative stress, its causal role remains debated. Further clinical and basic science studies on hyperuricemia and purine metabolism are necessary to clarify its impact on CVD and guide therapeutic approaches.
dc.description.indexedbyWOS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.publisherscopeInternational
dc.description.sponsoredbyTubitakEuN/A
dc.description.sponsorshipThis study was supported by research grants from JSPS KAKENHI Grant (20K17168 and 23K07493);the Japanese Society of Gout and Uric and Nucleic Acid;and the Gout and Uric Acid Foundation of Japan
dc.identifier.doi10.1038/s41440-024-02031-9
dc.identifier.eissn1348-4214
dc.identifier.grantnoJSPS KAKENHI Grant [20K17168, 23K07493];Japanese Society of Gout and Uric Nucleic Acid;Gout and Uric Acid Foundation of Japan
dc.identifier.issn0916-9636
dc.identifier.issue2
dc.identifier.quartileQ1
dc.identifier.scopus2-s2.0-85211489419
dc.identifier.urihttps://doi.org/10.1038/s41440-024-02031-9
dc.identifier.urihttps://hdl.handle.net/20.500.14288/27475
dc.identifier.volume48
dc.identifier.wos1368856500001
dc.keywordsUric acid
dc.keywordsHyperuricemia
dc.keywordsPreeclampsia
dc.keywordsCardiovascular disease
dc.keywordsAssociation
dc.language.isoeng
dc.publisherSpringer Nature
dc.relation.ispartofHYPERTENSION RESEARCH
dc.subjectPeripheral vascular disease
dc.titleCurrent updates and future perspectives in uric acid research, 2024
dc.typeReview
dspace.entity.typePublication
local.contributor.kuauthorKanbay, Mehmet
local.publication.orgunit1SCHOOL OF MEDICINE
local.publication.orgunit2School of Medicine
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication.latestForDiscoveryd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublication.latestForDiscovery17f2dc8e-6e54-4fa8-b5e0-d6415123a93e

Files